Go to the list of all blogs
Niko Sharks's Avatar
published in Blogs
May 08, 2019
TickeronGET DAILY SIGNALS
Mylan Suffers Biggest Drop in Almost Two Decades Amid Drug Pain - Yahoo Finance

Mylan Suffers Biggest Drop in Almost Two Decades Amid Drug Pain - Yahoo Finance

Mylan NV fell the most in 19 years after the drugmaker offered no updates on a strategic review that has been going on for 10 months as its businesses struggle around the globe.

Read More...

Related Ticker: MYL
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceuticals

Industry NotClassified

Industry
Pharmaceuticals Generic
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Xerox Holdings Corporation (XRX) stock price surged +114% over the past 30 days, driven primarily by a strong Q1 2026 revenue beat from the Lexmark acquisition. Over the past quarter, XRX is up +17%, recovering from mid-period lows amid volatile trading and financial concerns.
ExxonMobil reported GAAP net earnings of $4.2 billion, or $1.00 per diluted share (EPS), down from $7.7 billion, or $1.76 per share, in Q1 2025. Adjusted earnings excluding identified items reached $4.9 billion, or $1.16 per share, surpassing consensus estimates around $1.00 to $1.07.
Mylan Suffers Biggest Drop in Almost Two Decades Amid Drug Pain - Yahoo Finance